Anestesia venosa total (AVT) em lactente com doença de Werdnig-Hoffmann: relato de caso
Total intravenous anesthesia (TIVA) in an infant with Werdnig-Hoffmann disease: case report
Marco Antonio Cardoso de Resende; Elizabeth Vaz da Silva; Osvaldo José Moreira Nascimento; Alberto Esteves Gemal; Giseli Quintanilha; Eliana Maria Vasconcelos
Resumo
Palavras-chave
Abstract
Keywords
Referências
Kaufman P, Finkel R. Learning to walk: challenges for spinal muscular atrophy clinical trials. Neurology. 2007;68:11-12.
Menkes JH, Sarnat HB. Diseases of the Motor Unit. Child Neurology. 2000:469-471.
Hardart MKM, Truog RD. Spinal muscular atrophy-type I. Arch Dis Child. 2003;88:848-850.
Cobben JM, Lemmink HH, Snoeck I. Survival in SMA type I: a prospective analysis of 34 consecutive cases. Neuromuscul Disord. 2008;18:541-544.
Chung BHY, Wong VCN, Ip P. Spinal muscular atrophy: survival pattern and functional status. Pediatrics. 2004;114:e548-553.
Prior TW. Spinal muscular atrophy diagnostics. J Child Neurol. 2007;22:952-956.
Burlet P, Burglen L, Clermont O. Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease. J Med Genet. 1996;33:281-283.
Baranov D, Kelton T, McClung H. Neurologic Diseases. Anesthesia and Uncommon Diseases. 2006.
Carvalho M. Anestesia para crianças hipotônicas. CEDAR. 2004:4-7.
Bush A, Fraser J, Jardine E. Respiratory management of the infant with type 1 spinal muscular atrophy. Arch Dis Child. 2005;90:709-711.
Videira RLR, Cruz JRS. Remifentanil na prática clínica. Rev Bras Anestesiol. 2004;54:114-128.
Martins CEC, Albuquerque MAC, Simoni RF. Remifentanil. Curso de Educação à Distância em Anestesiologia. 2007:126-145.
Ehran E, Ugur G, Gunusen I. Propofol: not thiopental or etomidate - with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade. Can J Anaesth. 2003;50:108-15.
Batra YK, Al Qattan AR, Ali SS. Assessment of tracheal intubating conditions in children using remifentanil and propofol without muscle relaxant. Paediatr Anaesth. 2004;14:452-456.
Crawford MW, Hayes J, Tan JM. Dose-response of remifentanil for tracheal intubation in infants. Anesth Analg. 2005;100:1599-1604.
Morgan JM, Barker I, Peacock JE. A comparison of intubating conditions in children following induction of anaesthesia with propofol and suxamethonium or propofol and remifentanil. Anaesthesia. 2007;62:135-139.
Kretz FJ. The future of paediatric anaesthesia is total intravenous anaesthesia. Curr Opin Anaesthesiol. 2002;15:305-307.
Nora FS, Fortis EAF. Remifentanil: por que precisamos de outro opióide?. Rev Bras Anestesiol. 2001;51:146-159.
Nora FS, Klipel R, Ayala G. Remifentanil: o regime de infusão faz diferença na prevenção das respostas circulatórias à intubação traqueal?. Rev Bras Anestesiol. 2007;57:247-260.
Wysowski DK, Pollock ML. Reports of Death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review. Anesthesiology. 2006;105:1047-1051.
Wolf AR, Potter F. Propofol infusion in children: when does an anesthetic tool become an intensive care liability. Pediatr Anesth. 2004;14:435-438.
Burow BK, Johnson ME, Packer DL. Metabolic acidosis associated with propofol in the absence of other causative factors. Anesthesiology. 2004;101:239-241.
Muñoz HR, Cortinez LI, Ibacache ME. Remifentanil requirements during propofol administration to block the somatic response to skin incision in children and adults. Anesth Analg. 2007;104:77-78.
Lerman J, Johr M. Inhalational anesthesia vs total intravenous anesthesia (TIVA) for pediatric anesthesia. Pediatr Anesth. 2009;19:521-534.
Flick RP, Gleich SJ, Herr MMH. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder. Pediatr Anesth. 2007;17:22-27.